Metrics From Wearable Devices Can Predict IBD Flares
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 24, 2025 -- Physiological metrics from wearable devices can help identify inflammatory bowel disease (IBD) flares, according to a study published online Jan. 16 in Gastroenterology.
Robert P. Hirten, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues examined the predictive abilities of physiological metrics, measured using wearable devices in patients with IBD. A total of 309 patients were enrolled across 36 states.
The researchers found significant differences in circadian patterns of heart rate variability between periods of inflammatory flare and remission and between symptomatic flare and remission. During periods of inflammatory flare and symptomatic flare, marginal means for longitudinal heart rate and resting heart rate were higher. During inflammatory flares, lower daily steps were recorded. Heart rate variability, heart rate, and resting heart rate could establish the presence of inflammation among patients with symptoms. Up to seven weeks prior to inflammatory and symptomatic flares, heart rate variability, heart rate, resting heart rate, steps, and oxygenation were significantly altered.
"These findings open the door to leveraging wearable technology for health monitoring and disease management in innovative ways we haven't previously considered," Hirten said in a statement. "Our hope is that, in the future, this approach will significantly enhance the quality of life of our patients."
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-25 06:00
Read more
- First U.S. Death From Bird Flu Reported in Louisiana
- Electronic Patient-Reported Outcome Monitoring System Beneficial
- Blood Test May Help Predict How Long Immunity Lasts
- Singapore Is Ready for a Rapidly Aging Society, Study Says. What About the U.S.?
- Humanetics Corporation Announces Positive Phase 2 Clinical Trial Results in COVID-19 Study Aimed at Improving Pulmonary Function
- FDA Approves Marketing of Nicotine Pouches
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions